all report title image
  • Published On : Feb 2024
  • Code : CMI4804
  • Pages :224
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

The global parenteral nutrition market was valued US$ 4,548.7 Mn in 2023 and is expected to reach US$ 7,251 Mn by 2031 growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

Parenteral nutrition, also known as total parenteral nutrition (TPN), is a method of feeding people who cannot or should not eat or digest regular food. Liquid foods are delivered directly into the veins through an intravenous catheter that bypasses the normal process of eating and digestion. Parenteral nutrition provides nutrients such as proteins, carbohydrates, vitamins, minerals, and fats which are essential for the body's growth and repair processes. It is primarily used for people who cannot be fed through oral or enteral route either temporarily or long-term. Parenteral nutrition helps prevent malnutrition, weight loss, and other complications in chronically or critically ill patients.

Global Parenteral Nutrition Market - Regional Insights

  • North America is expected to be the largest market for parenteral nutrition during the forecast period, accounting for over 37.1% of the market share in 2024. North America is expected to hold a dominant position in the global parenteral nutrition market over the forecast period, owing to the increasing number of product launches or approvals.
  • Asia Pacific is expected to be the second-largest market for parenteral nutrition, accounting for over 20.6% of the market share in 2024. Rapid economic development, increasing healthcare investments, and rising medical tourism in China and India will augment the regional market growth.

Figure 1. Global Parenteral Nutrition Market Share (%), By Region, 2024

PARENTERAL NUTRITION MARKET

Analyst View:

The global parenteral nutrition market is expected to witness steady growth in the coming years. Increased prevalence of chronic diseases worldwide requiring parenteral nutritional support will be a key growth driver. A rise in geriatric population prone to malnutrition is also favoring the market expansion. Additionally, the ability of parenteral nutrition to offer complete nutritional support especially for patients who cannot maintain sufficient oral intake is boosting its adoption. However, risks of catheter-related bloodstream infections and other complications with long-term parenteral nutrition may negatively impact the market to some extent.

Global Parenteral Nutrition Market - Drivers

  • Increasing Collaborations by Key Market Players: The increasing adoption of inorganic growth strategies such as collaborations is expected to drive the global parenteral nutrition market growth over the forecast period. For instance, on June 1, 2023, Nestlé Health Science, a subsidiary company of Nestlé SA, announced a collaboration with Indian Association for Parenteral and Enteral Nutrition (IAPEN) to strengthen awareness on Gut Health Management. Through the collaboration, Nestlé Health Science reached out to more than 800 Healthcare Practitioners (HCPs) across 26 chapters of IAPEN.
  • Increasing Product Launch by Key Market Players: Increasing product launch by key market players is expected to drive the global parenteral nutrition market. For instance, In November 2020, Otsuka Holdings Co., Ltd., a pharmaceutical company, announced the launch of ENEFLUID Injection, the amino acid, glucose, electrolyte, fat, and water-soluble vitamin injection. This ENEFLUID is the first peripheral parenteral nutrition solution in Japan that combines fat and water-soluble vitamins in addition to glucose, electrolytes, and amino acids in a dual-chamber bag. By compounding fat, more calories can be administered than the approved glucose, electrolyte, and amino acid infusions, and by compounding nine water-soluble vitamins.

Global Parenteral Nutrition Market - Opportunities

  • Emergence of enhanced parenteral nutrition solutions: One of the major opportunities for the market is the emergence of enhanced parenteral nutrition solutions which are more effective in delivering optimal nutrition. The development of advanced formulations that can better mimic physiological nutrition absorption is a key focus area among major players. These enhanced formulations help meet the complete nutritional needs of patients more efficiently. For example, many new products entering the market contain balanced mixtures of carbohydrates, proteins, fats, electrolytes, vitamins, and minerals customized for different clinical conditions and needs. This helps maximize the benefits and minimize the risks associated with parenteral nutrition therapy.

Parenteral Nutrition Market Report Coverage

Report Coverage Details
Base Year: 2023 Market Size in 2023: US$ 4,548.7 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2024 to 2031 CAGR: 6.1% 2031 Value Projection: US$ 7,251 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa 
Segments covered:
  • By Nutrition Type: Carbohydrates, Lipid Emulsion, Vitamins and Trace Minerals, Proteins, Others (Amino acids, etc.)
  • By  Patient Type: Infants, Adults, Geriatric
  • By Application: Diabetes, Renal Failures, Obesity, Sarcopenia, Cancer, Others (Digestive disorders, Metabolic Syndromes, etc.)
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

AbbVie Inc., Danone, Fresenius Kabi AG, GENTAG, Inc., GSK plc., Nestlé SA, Nutricia, Sun Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi, Otsuka Holdings Co., Ltd., and Otsuka Holdings Co., Ltd.

Growth Drivers:
  • Increasing collaborations by key market players
  • Increasing product launch by key market players
Restraints & Challenges:
  • Lack of awareness regarding healthcare, diet, and proper nutrition

Global Parenteral Nutrition Market – Trends

  • Rise in awareness about clinical nutrition: The growing awareness about clinical nutrition among consumers and healthcare professionals is significantly impacting the global parenteral nutrition market. There is a rising understanding that proper clinical nutrition is essential for improving health outcomes, especially for critically ill patients or those undergoing surgery or cancer treatment. Parenteral nutrition helps ensure patients receive adequate nutrients when they are unable to consume food or absorb nutrients orally or enterally.
  • Shift towards single-dose parenteral nutrition products: The global parenteral nutrition market is witnessing a notable shift towards single-dose parenteral nutrition products. With growing preference for convenience and safety, pharmaceutical companies are increasingly investing in the development of ready-to-use single-dose parenteral nutrition bags that eliminate the need for compounding. This trend addresses key concerns regarding contamination risks associated with compounded parenteral nutrition and reduces preparation time for caregivers.

Global Parenteral Nutrition Market - Restraints

  • Lack of awareness regarding healthcare, diet, and proper nutrition: Lack of awareness regarding healthcare, diet, and proper nutrition in low and middle income economies such as Africa and Asia Pacific is a major factor hampering the growth of the global parenteral nutrition market. There is low awareness regarding nutritional products and diseases associated with nutritional deficiencies in rural areas of low and middle income economies in Africa and Asia Pacific due to lack of healthcare professionals. For instance, according to data published by the National Center for Biotechnology Information in March 2020, African countries have around 2.3 healthcare workers per 1,000 population.
  • Counterbalance – To counterbalance the lack of awareness regarding healthcare, diet, and proper nutrition, a multipronged approach is necessary, encompassing education, public health initiatives, policy making, and community engagement.

Figure 2. Global Parenteral Nutrition Market Share (%), By Nutrition Type, 2023

PARENTERAL NUTRITION MARKET

Global Parenteral Nutrition Market - Recent Developments

  • In February 2022, The Pharmasyntez Group of companies, a healthcare company, invested in the construction of the plant to launch the parenteral (intravenous) nutrition department in Primorye, Russia.
  • In November 2021, Fresenius Kabi AG, a global healthcare company, announced the winner of its innovative JUMPstart education program and research grant. JUMPstart is an initiative that aims to nurture research in the field of parenteral nutrition through the mentoring, education and networking of clinicians and researchers. The grant is awarded to help to advance novel, community-led research in parenteral nutrition, to make a difference for critically ill patients.
  • In February 2021, Fresenius Kabi AG, a global healthcare company, announced its plans to expand its Austrian facilities. The company will invest more than US$ 69.4 million through to expand capacity and upgrade infrastructure at its production plant in Graz and packaging center nearby Werndorf, Austria.

Top Companies in Global Parenteral Nutrition Market

  • AbbVie Inc.
  • Danone
  • Fresenius Kabi AG
  • GENTAG, Inc.
  • GSK plc.
  • Nestlé SA
  • Nutricia
  • Sun Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Sanofi
  • Otsuka Holdings Co., Ltd.
  • VIRIDIAN SA

Definition: Parenteral nutrition is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to cure or prevent malnutrition. Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals, and electrolytes. Some people use parenteral nutrition to feed various vitamin or protein supplements through a tube placed into the stomach or small bowel.

Frequently Asked Questions

Lack of awareness regarding healthcare, diet, and proper nutrition are the key factor hampering growth of the global parenteral nutrition market.

Increasing collaborations by key market players and increasing product launch by key market players are the major factors driving the global parenteral nutrition market growth.

Carbohydrates segment is the leading nutrition type segment in the global parenteral nutrition market.

The major players operating in the global parenteral nutrition market are AbbVie Inc., Danone, Fresenius Kabi AG, GENTAG, Inc., GSK plc, Nestlé SA, Nutricia, Sun Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi, Otsuka Holdings Co., Ltd., and Otsuka Holdings Co., Ltd.

North America leads the global parenteral nutrition market.

The CAGR of the global parenteral nutrition market is 6.1%

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo